Lumasiran OverviewLumasiran, sold under the brand name Oxlumo, is a medication for the treatment of primary hyperoxaluria type 1 (PH1). The most common side effects include injection site reactions and abdominal pain. Lumasiran is a double-stranded small interfering ribonucleic acid (siRNA) that reduces levels of glycolate oxidase (GO) enzyme by targeting the HAO1 messenger ribonucleic acid (mRNA) in hepatocytes through RNA interferenc...
Read more Lumasiran Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lumasiran
Recent Lumasiran Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 94.5mg/0.5ml, 94.5mg/0.5ml (94.5mg/0.5ml)
Other drugs which contain Lumasiran or a similar ingredient: (1 result)
- OXLUMO Lumasiran